Articles

The latest rally in U.S. stock futures stalled as traders eyed a busy few days containing inflation updates and the start of the corporate earnings season.

The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.

In interviews with the Wall Street Journal and Bloomberg News, Wentworth -- the former CEO of pharmacy-benefits manager Express Scripts -- said he will take over Walgreens' top spot.

Samsung Electronics expects its third-quarter operating profit to fall 78% from a year earlier, which would miss market expectations, as its flagship semiconductor business is seen as still struggling to exit an industry downturn.

23andMe said that the profile information of some customers was accessed without their permission by a third party.

CleanCore Solutions has filed for an initial public offering with the Securities and Exchange Commission.

Australia's biggest airline, Qantas Airways, said Chairman Richard Goyder and other board members would step down as the company seeks to repair its battered reputation among customers.

German sandal maker Birkenstock has reportedly priced its initial public offering at $46 a share, on the low end of its expected range, as investors remain cautious about new public debuts.

Family Dollar voluntarily recalled dozens of OTC drugs and medical devices sold at its stores because they had been stored at improper temperatures.

A rout in Treasury bonds that has helped trample stocks and revive recession fears in the U.S. took a breather on Monday, as long-dated Treasury yields recorded their biggest pullback since March.

Block shares have seen a "massive pullback" since the end of July, but a BofA analyst predicts a buying opportunity in the payment-technology name.

Minneapolis Fed President Neel Kashkari said Tuesday that the runup in the 10-year Treasury yields is 'a little bit perplexing,'